News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,117 Results
Type
Article (16026)
Company Profile (295)
Press Release (267796)
Section
Business (85740)
Career Advice (157)
Deals (14915)
Drug Delivery (32)
Drug Development (52633)
Employer Resources (31)
FDA (6538)
Job Trends (5573)
News (156154)
Policy (11504)
Tag
Academia (948)
Allergies (58)
Alliances (23179)
Alzheimer's disease (734)
Approvals (6500)
Artificial intelligence (61)
Bankruptcy (113)
Best Places to Work (4700)
Biotechnology (243)
Breast cancer (61)
Cancer (634)
Cardiovascular disease (52)
Career advice (137)
CAR-T (48)
Cell therapy (158)
Clinical research (41542)
Collaboration (214)
Compensation (90)
COVID-19 (1202)
C-suite (61)
Cystic fibrosis (62)
Data (694)
Diabetes (72)
Diagnostics (1385)
Earnings (31385)
Events (49015)
Executive appointments (167)
FDA (6803)
Funding (214)
Gene editing (52)
Gene therapy (131)
GLP-1 (298)
Government (1232)
Healthcare (6962)
Infectious disease (1237)
Inflammatory bowel disease (90)
IPO (7614)
Job creations (1106)
Job search strategy (132)
Layoffs (189)
Legal (1872)
Lung cancer (106)
Manufacturing (69)
Medical device (2931)
Medtech (2932)
Mergers & acquisitions (7376)
Metabolic disorders (216)
Neuroscience (919)
NextGen Class of 2024 (2083)
Non-profit (919)
Northern California (846)
Obesity (121)
Opinion (93)
Parkinson's disease (55)
Patents (48)
People (26720)
Pharmaceutical (48)
Phase I (14316)
Phase II (19057)
Phase III (12532)
Pipeline (221)
Postmarket research (1076)
Preclinical (6051)
Radiopharmaceuticals (203)
Rare diseases (146)
Real estate (1565)
Regulatory (9035)
Research institute (987)
Southern California (785)
Startups (2039)
United States (7122)
Vaccines (198)
Weight loss (75)
Date
Last 7 days (651)
Last 30 days (1980)
Last 365 days (21198)
2024 (18717)
2023 (23278)
2022 (29034)
2021 (29897)
2020 (25390)
2019 (17459)
2018 (12732)
2017 (14993)
2016 (13179)
2015 (16110)
2014 (11760)
2013 (8510)
2012 (8601)
2011 (8633)
2010 (8444)
Location
Africa (177)
Asia (17487)
Australia (2946)
California (1919)
Canada (669)
China (143)
Colorado (70)
Connecticut (75)
Europe (47107)
Florida (203)
Georgia (56)
Illinois (121)
Indiana (59)
Kansas (56)
Maryland (294)
Massachusetts (1593)
Minnesota (86)
New Jersey (530)
New York (572)
North Carolina (420)
Northern California (846)
Ohio (73)
Pennsylvania (408)
South America (234)
Southern California (785)
Texas (198)
Washington State (208)
284,117 Results for "allergy therapeutics plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allergy Diagnostics and Therapeutics Market Size is Expanding around US$ 66.60 Billion by 2033
September 12, 2024
·
11 min read
Genetown
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
Astria Therapeutics, Inc. today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
May 23, 2024
·
1 min read
Genflow Biosciences Plc Announces Result of AGM
Genflow Biosciences Plc an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that all resolutions proposed at the Annual General Meeting held earlier were duly passed.
June 27, 2024
·
1 min read
Press Releases
Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
October 30, 2024
·
1 min read
Mergers & acquisitions
UCB Offloads Neurology, Allergy Portfolio in China for $680M
Belgium-based biopharma UCB is selling its Chinese neurology and allergy business to Singapore asset management firm CBC Group and Abu Dhabi investment company Mubadala.
August 26, 2024
·
1 min read
·
Annalee Armstrong
News
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
October 21, 2024
·
1 min read
Genetown
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - May 24, 2024
Astria Therapeutics, Inc., a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, announced that it will present final STAR-0215 Phase 1a healthy subject data in an encore presentation at the upcoming Eastern Allergy Conference in Palm Beach, Florida on June 1, 2024.
May 24, 2024
·
1 min read
Business
Logix Biosciences Enters into Agreement with Mayo Clinic to Advance Development of Therapeutics for Allergy Relief, Mutating Infectious Diseases and Antimicrobial Resistance
Logix Biosciences, a biopharmaceutical company focused on the discovery and development of a pipeline of precision therapeutics and companion diagnostics for allergy relief, protection against infectious diseases, and antimicrobial resistance (AMR), today announced it has entered into a know-how agreement with Mayo Clinic.
June 12, 2024
·
2 min read
Pharm Country
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Intrommune Therapeutics, Inc. today announced data from The First Study To Evaluate Oral Mucosal Immunotherapy (OMIT) For The Treatment Of Food Allergy has been selected as a Late Breaking Poster Presentation at the 2024 American Academy of Allergy, Asthma & Immunology in Washington, DC.
February 6, 2024
·
3 min read
ICON plc to Present at the 2024 Jefferies Global Healthcare Conference
ICON plc, a world-leading healthcare intelligence and clinical research organization, announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.
June 4, 2024
·
2 min read
1 of 28,412
Next
